Status:
WITHDRAWN
Omics of Cancer: OncoGenomics
Lead Sponsor:
National Cancer Institute (NCI)
Conditions:
Neoplasms
Cancer
Eligibility:
All Genders
4+ years
Brief Summary
Background: Cancer is a leading cause of death in the United States. Researchers want to know more about how cancer develops and grows. They want to understand more about cancers that run in families...
Detailed Description
Background * Cancer is the second leading cause of disease-related mortality in the US and the primary leading cause of US disease-related mortality in individuals aged 40-79 * One of the missions of...
Eligibility Criteria
Inclusion
- INCLUSION CRITERIA:
- Age \>= 4 weeks
- Participants must have:
- diagnosis of any tumor, malignancy, pre-malignant disorder
- OR
- evidence of an inherited cancer syndrome based on family history and/or other manifestations of the syndrome (i.e., polyposis, plexiform neurofibromas, myelodysplastic syndrome)
- Participants must
- have biospecimen (e.g., tumor, normal, blood, bone marrow, serum, plasma, or any other specimen) that has been previously collected and is available for research analysis
- OR
- -be scheduled to undergo surgery or biopsy for routine patient care on another research or standard of care protocol
- OR
- -be willing to provide blood and/or saliva specimens. Note: does not apply to children \< 3 years old
- The ability of participant or parent/guardian to understand and the willingness to sign a written consent document.
- EXCLUSION CRITERIA:
- None
Exclusion
Key Trial Info
Start Date :
September 27 2023
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 27 2023
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT05431439
Start Date
September 27 2023
End Date
September 27 2023
Last Update
September 29 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Institutes of Health Clinical Center
Bethesda, Maryland, United States, 20892